Overview |
bs-9629R-Cy7 |
C16orf7 Polyclonal Antibody, Cy7 Conjugated |
WB, IF(IHC-P) |
Human, Mouse, Rat |
Specifications |
Cy7 |
Rabbit |
KLH conjugated synthetic peptide derived from human C16orf7/ATP-BL |
25-130/631 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
ATP BL; C16orf7; Chromosome 16 open reading frame 7; CP007_HUMAN; Protein ATP-BL; Uncharacterized protein C16orf7. |
Chromosome 16 encodes over 900 genes in approximately 90 million base pairs, makes up nearly 3% of human cellular DNA and is associated with a variety of genetic disorders. The GAN gene is located on chromosome 16 and, with mutation, may lead to giant axonal neuropathy, a nervous system disorder characterized by increasing malfunction with growth. The rare disorder Rubinstein-Taybi syndrome is also associated with chromosome 16, though through the CREBBP gene which encodes a critical CREB binding protein. Signs of Rubinstein-Taybi include mental retardation and predisposition to tumor growth and white blood cell neoplasias. Crohn's disease is a gastrointestinal inflammatory condition associated with chromosome 16 through the NOD2 gene. An association with systemic lupus erythematosis and a number of other autoimmune disorders with the pericentromeric region of chromosome 16 has led to the identification of SLC5A11 as a potential autoimmune modifier. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |